⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Cytovale and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Cytovale
↗San Francisco, USA
Cytovale is a commercial-stage medical diagnostics company dedicated to advancing early detection technologies for fast-moving and immune-mediated diseases. The company's flagship product, IntelliSep, is an FDA-cleared diagnostic tool that uses microfluidics and machine learning to analyze the biophysical properties of white blood cells, providing sepsis risk stratification in approximately eight minutes.
Founded in 2013, the company originated from academic research and has since transitioned into a commercial-stage entity. By providing rapid, objective diagnostic insights in emergency department settings, Cytovale aims to improve clinical decision-making, optimize hospital resource allocation, and ultimately reduce mortality rates associated with conditions like sepsis.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2013
Ownership:private
Status:operating
FUNDING
Stage:Series D
Total Raised:$228M
Investors:Sands Capital, Canada Pension Plan Investment Board (CPP Investments), Norwest Venture Partners, Global Health Investment Corporation, Breakout Ventures
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (IntelliSep)
Modalities:Microfluidics, Machine Learning, Deformability Cytometry
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Hospital health systems (various US-based emergency departments)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Ajay Shah - CEO & Co-Founder
Fe Batara - EVP, People
Scientific Founders:Ajay Shah, Dino Di Carlo
LINKS
Website:cytovale.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cytovale. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.